BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alkahtani HM, Abdalla AN, Obaidullah AJ, Alanazi MM, Almehizia AA, Alanazi MG, Ahmed AY, Alwassil OI, Darwish HW, Abdel-aziz AA, El-azab AS. Synthesis, cytotoxic evaluation, and molecular docking studies of novel quinazoline derivatives with benzenesulfonamide and anilide tails: Dual inhibitors of EGFR/HER2. Bioorganic Chemistry 2020;95:103461. [DOI: 10.1016/j.bioorg.2019.103461] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Bhatia P, Sharma V, Alam O, Manaithiya A, Alam P, Kahksha, Alam MT, Imran M. Novel quinazoline-based EGFR kinase inhibitors: A review focussing on SAR and molecular docking studies (2015-2019). Eur J Med Chem 2020;204:112640. [PMID: 32739648 DOI: 10.1016/j.ejmech.2020.112640] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
2 Turky A, Bayoumi AH, Ghiaty A, El-Azab AS, A-M Abdel-Aziz A, Abulkhair HS. Design, synthesis, and antitumor activity of novel compounds based on 1,2,4-triazolophthalazine scaffold: Apoptosis-inductive and PCAF-inhibitory effects. Bioorg Chem 2020;101:104019. [PMID: 32615465 DOI: 10.1016/j.bioorg.2020.104019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
3 Burmaoglu S, Gobek A, Aydin BO, Yurtoglu E, Aydin BN, Ozkat GY, Hepokur C, Ozek NS, Aysin F, Altundas R, Algul O. Design, synthesis and biological evaluation of novel bischalcone derivatives as potential anticancer agents. Bioorg Chem 2021;111:104882. [PMID: 33839582 DOI: 10.1016/j.bioorg.2021.104882] [Reference Citation Analysis]
4 Zhang B, Liu Z, Xia S, Liu Q, Gou S. Design, synthesis and biological evaluation of sulfamoylphenyl-quinazoline derivatives as potential EGFR/CAIX dual inhibitors. Eur J Med Chem 2021;216:113300. [PMID: 33640672 DOI: 10.1016/j.ejmech.2021.113300] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Alqahtani AS, Ghorab MM, Nasr FA, Ahmed MZ, Al-Mishari AA, Attia SM. The Antiproliferative and Apoptotic Effects of a Novel Quinazoline Carrying Substituted-Sulfonamides: In Vitro and Molecular Docking Study. Molecules 2022;27:981. [PMID: 35164248 DOI: 10.3390/molecules27030981] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Fares S, Selim KB, Goda FE, El-Sayed MAA, AlSaif NA, Hefnawy MM, Abdel-Aziz AA, El-Azab AS. Design, synthesis, and analysis of antiproliferative and apoptosis-inducing activities of nitrile derivatives containing a benzofuran scaffold: EGFR inhibition assay and molecular modelling study. J Enzyme Inhib Med Chem 2021;36:1488-99. [PMID: 34227457 DOI: 10.1080/14756366.2021.1946044] [Reference Citation Analysis]
7 Abdelgawad MA, Musa A, Almalki AH, Alzarea SI, Mostafa EM, Hegazy MM, Mostafa-Hedeab G, Ghoneim MM, Parambi DGT, Bakr RB, Al-Muaikel NS, Alanazi AS, Alharbi M, Ahmad W, Bukhari SNA, Al-Sanea MM. Novel Phenolic Compounds as Potential Dual EGFR and COX-2 Inhibitors: Design, Semisynthesis, in vitro Biological Evaluation and in silico Insights. Drug Des Devel Ther 2021;15:2325-37. [PMID: 34103896 DOI: 10.2147/DDDT.S310820] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hamdi A, El-shafey HW, Othman DI, El-azab AS, Alsaif NA, A.-m. Abdel-aziz A. Design, synthesis, antitumor, and VEGFR-2 inhibition activities of novel 4-anilino-2-vinyl-quinazolines: Molecular modeling studies. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.105710] [Reference Citation Analysis]
9 Wang J, Liu R, Zhao Y, Ma Z, Sang Z, Wen Z, Yang X, Xie H. Novel Microcrystal Formulations of Sorafenib Facilitate a Long-Acting Antitumor Effect and Relieve Treatment Side Effects as Observed With Fundus Microcirculation Imaging. Front Oncol 2021;11:743055. [PMID: 34513717 DOI: 10.3389/fonc.2021.743055] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 El-Azab AS, Abdel-Aziz AA, Bua S, Nocentini A, AlSaif NA, Alanazi MM, El-Gendy MA, Ahmed HEA, Supuran CT. S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors. J Enzyme Inhib Med Chem 2020;35:733-43. [PMID: 32189526 DOI: 10.1080/14756366.2020.1742117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 El-Azab AS, Abdel-Aziz AA, Ahmed HEA, Bua S, Nocentini A, AlSaif NA, Obaidullah AJ, Hefnawy MM, Supuran CT. Exploring structure-activity relationship of S-substituted 2-mercaptoquinazolin-4(3H)-one including 4-ethylbenzenesulfonamides as human carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2020;35:598-609. [PMID: 32009479 DOI: 10.1080/14756366.2020.1722121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Abdalla AN, Malki WH, Qattan A, Shahid I, Hossain MA, Ahmed M. Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer. Molecules 2021;26:E334. [PMID: 33440689 DOI: 10.3390/molecules26020334] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
13 Li A, Yang Y, Wang W, Liu Q, Sun Y, Gu W. Synthesis, cytotoxicity and apoptosis‐inducing activity of novel 1 H ‐benzo[ d ]imidazole derivatives of dehydroabietic acid. J Chin Chem Soc 2020;67:1668-78. [DOI: 10.1002/jccs.202000075] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Abdallah ME, El-Readi MZ, Althubiti MA, Almaimani RA, Ismail AM, Idris S, Refaat B, Almalki WH, Babakr AT, Mukhtar MH, Abdalla AN, Idris OF. Tamoxifen and the PI3K Inhibitor: LY294002 Synergistically Induce Apoptosis and Cell Cycle Arrest in Breast Cancer MCF-7 Cells. Molecules 2020;25:E3355. [PMID: 32722075 DOI: 10.3390/molecules25153355] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
15 Abdalla AN, Abdallah ME, Aslam A, Bader A, Vassallo A, Tommasi N, Malki WH, Gouda AM, Mukhtar MH, El-Readi MZ, Alkahtani HM, Abdel-Aziz AA, El-Azab AS. Synergistic Anti Leukemia Effect of a Novel Hsp90 and a Pan Cyclin Dependent Kinase Inhibitors. Molecules 2020;25:E2220. [PMID: 32397330 DOI: 10.3390/molecules25092220] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
16 Zou M, Li J, Jin B, Wang M, Chen H, Zhang Z, Zhang C, Zhao Z, Zheng L. Design, synthesis and anticancer evaluation of new 4-anilinoquinoline-3-carbonitrile derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers. Bioorg Chem 2021;114:105200. [PMID: 34375195 DOI: 10.1016/j.bioorg.2021.105200] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Sait KHW, Mashraqi M, Khogeer AA, Alzahrani O, Anfinan NM, Sait HK, Almutairi A, Alam Q. Molecular docking analysis of HER-2 inhibitor from the ZINC database as anticancer agents. Bioinformation 2020;16:882-7. [PMID: 34803263 DOI: 10.6026/97320630016882] [Reference Citation Analysis]
18 Abdalla AN, Qattan A, Malki WH, Shahid I, Hossain MA, Ahmed M. Significance of Targeting VEGFR-2 and Cyclin D1 in Luminal-A Breast Cancer. Molecules 2020;25:E4606. [PMID: 33050377 DOI: 10.3390/molecules25204606] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
19 Abdel-Aziz AA, El-Azab AS, AlSaif NA, Obaidullah AJ, Al-Obaid AM, Al-Suwaidan IA. Synthesis, potential antitumor activity, cell cycle analysis, and multitarget mechanisms of novel hydrazones incorporating a 4-methylsulfonylbenzene scaffold: a molecular docking study. J Enzyme Inhib Med Chem 2021;36:1521-39. [PMID: 34266349 DOI: 10.1080/14756366.2021.1924698] [Reference Citation Analysis]
20 Karan R, Agarwal P, Sinha M, Mahato N. Recent Advances on Quinazoline Derivatives: A Potential Bioactive Scaffold in Medicinal Chemistry. ChemEngineering 2021;5:73. [DOI: 10.3390/chemengineering5040073] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 El-Azab AS, Abdel-Aziz AA, AlSaif NA, Alkahtani HM, Alanazi MM, Obaidullah AJ, Eskandrani RO, Alharbi A. Antitumor activity, multitarget mechanisms, and molecular docking studies of quinazoline derivatives based on a benzenesulfonamide scaffold: Cell cycle analysis. Bioorg Chem 2020;104:104345. [PMID: 33142413 DOI: 10.1016/j.bioorg.2020.104345] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]